The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates
Abstract
LY-CoV555, a SARS-CoV-2 spike protein–specific antibody, neutralizes SARS-CoV-2 and protects the airways of nonhuman primates against infection.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- May 12, 2021
- Source ID
- 10.1126/scitranslmed.abf1906
Entities
People
- Adil Mohamed
- Andrew C. Adams
- Anna Pustilnik
- Barney S. Graham
- Beverly A. Heinz
- Bryan C. Barnhart
- Bryan Jones
- Carl L. Hansen
- Ching-Lin Hsieh
- Christopher M. Wiethoff
- Daniel Wrapp
- David R. Martinez
- David W. Collins
- Davide Pellacani
- Deepa Balasubramaniam
- Denisa Foster
- Ester Falconer
- Eun Sung Yang
- Franz J. Triana
- Hayley M Belli
- J. Hendle
- Jamie L. Blackbourne
- Jason S. McLellan
- John R. Mascola
- Jory A. Goldsmith
- Julian Davies
- Kathryn Westendorf
- Kevin R. Jepson
- Kizzmekia Corbett
- Krithika Muthuraman
- Lingshu Wang
- Lucas Kraft
- Maia A. Smith
- Maren de Vries
- Marie I. Samanovic
- Marissa H. Piper
- Mark J. Mulligan
- Meike Dittmann Chevillotte
- Nicole V Johnson
- Olubukola Abiona
- Patricia Brown‐Augsburger
- Ping Xiang
- Ralph S. Baric
- Richard E. Higgs
- Robert W Cross
- Rodrigo Goya
- Roza Bidshahri
- Samuel H Hinshaw
- Sean A. Tycho
- Shawn J. Berens
- Solmaz Sobhanifar
- Stefanie Žentelis
- Thomas Cujec
- Thomas W Geisbert
- Viktoriya Borisevich
- Yi Zhang
- Yuri Hwang
Organizations
- Eli Lilly and Company
- G. Harold & Leila Y. Mathers Foundation
- National Institute of Allergy and Infectious Diseases
- National Institutes of Health
- New York University
- United States Department of Energy
- University of North Carolina at Chapel Hill
- University of Texas Medical Branch
- University of Texas at Austin